MCG Post MI study
Research type
Research Study
Full title
A prospective single-centre pilot study to assess a magnetocardiograph device in patients following myocardial infarction.
IRAS ID
239578
Contact name
Lynda Unitt
Contact email
Sponsor organisation
Creavo Medical Technologies
Clinicaltrials.gov Identifier
Duration of Study in the UK
0 years, 4 months, 0 days
Research summary
The study is being performed to evaluate a new portable medical device, the Creavo Vitalscan Magnetocardiograph (Vitalscan), that may help doctors to differentiate between people who are having a heart attack and those who are not. Patients who have had a confirmed myocardial infarction (heart attack) within the previous 12 weeks will be approached to take part in the study.\n\nVitalscan is a CE-marked device, indicating it is considered to be safe and effective. It is a passive, non-contact imaging device that detects the magnetic fields produced by heart activity. It uses induction coils to produce an image of the magnetic field around the heart. It has been shown that the magnetic fields of people who are having a heart attack are different from those who are not.\n\nThe objective of the study is to evaluate scan images for patients who have had a recent heart attack and compare these to scan images from healthy volunteers taken previously. The images from the current device can then be assessed against images from an earlier version of the device.
REC name
South West - Central Bristol Research Ethics Committee
REC reference
17/SW/0293
Date of REC Opinion
21 Dec 2017
REC opinion
Further Information Favourable Opinion